Actively Recruiting
The Immune Response to Stroke
Led by University of Oslo · Updated on 2022-03-14
40
Participants Needed
1
Research Sites
414 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.
CONDITIONS
Official Title
The Immune Response to Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Stroke less than 72 hours ago
- Age over 18 years
You will not qualify if you...
- Brain hemorrhage confirmed by CT or MRI scan
- Previous or current immune system disease or other serious health conditions
- Ongoing immune response due to infection or vaccination within the last month
- Cognitive impairment preventing understanding or giving informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Akershus University Hospital
Lørenskog, Norway
Actively Recruiting
Research Team
A
Andreas Lossius, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here